Imagine a bridge connecting hospital specialists and home-care doctors so patients with severe lung disease don't keep bouncing back to the ER. It's like a coordinated care plan that focuses on comfort and quality of life rather than just treating the disease. This ensures patients get the right support at home and avoid unnecessary hospital stays.
Advanced COPD patients suffer from severe symptoms and frequent hospitalizations because palliative care is not integrated into respiratory treatment. This creates a heavy financial and operational burden on healthcare systems.
A standardized European version of the ICLEAR-EU service model, including implementation manuals and a multi-country training package.
If you are a private hospital network dealing with high readmission rates for lung patients — this project developed the ICLEAR-EU service model that reduces hospitalizations. By integrating palliative care, you can optimize bed turnover and improve patient outcomes.
If you are a software provider dealing with fragmented communication between primary and secondary care — this project developed a standardized implementation manual for the ICLEAR-EU model. You can integrate these clinical pathways into your platform to automate patient escalation and review.
If you are an insurer dealing with the high cost of emergency COPD care — this project developed a cost-effectiveness evaluation across 6 countries. Using this evidence, you can incentivize the adoption of palliative care to lower long-term treatment costs.
Based on available project data, the specific price is not listed, but the project is explicitly evaluating the cost-effectiveness of the ICLEAR-EU intervention.
Yes, the project is testing the model in 18 hospitals across 6 European countries with 1,224 patients, demonstrating a clear path for international scaling.
Based on available project data, specific licensing terms are not mentioned, but the project is producing standardized implementation manuals for use across Europe.
It integrates by embedding palliative care into hospital-based respiratory care and strengthening links with community and primary care services.
The project runs from 2024-01-01 to 2028-12-31, with initial adaptation and training packages developed by June 2025.
The consortium is heavily academic, with 8 universities and 1 research institute. However, it includes 4 'Other' organizations and 1 industry SME, indicating a push toward practical application. With 14 partners across 7 countries, the group has the reach to validate the model across diverse European healthcare systems.
Contact Vrije Universiteit Brussel for partnership opportunities regarding the ICLEAR-EU model.
Contact SciTransfer to find a licensing partner for the ICLEAR-EU implementation manuals.
